Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 94 000 KRW -0.63% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Chong Kun Dang Pharmaceutical Corp?
Write Note

Intrinsic Value

The intrinsic value of one Chong Kun Dang Pharmaceutical Corp stock under the Base Case scenario is 98 114.35 KRW. Compared to the current market price of 94 000 KRW, Chong Kun Dang Pharmaceutical Corp is Undervalued by 4%.

Intrinsic Value
98 114.35 KRW
Undervaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Chong Kun Dang Pharmaceutical Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Chong Kun Dang Pharmaceutical Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Chong Kun Dang Pharmaceutical Corp?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Chong Kun Dang Pharmaceutical Corp

Provide an overview of the primary business activities
of Chong Kun Dang Pharmaceutical Corp.

What unique competitive advantages
does Chong Kun Dang Pharmaceutical Corp hold over its rivals?

What risks and challenges
does Chong Kun Dang Pharmaceutical Corp face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Chong Kun Dang Pharmaceutical Corp.

Provide P/S
for Chong Kun Dang Pharmaceutical Corp.

Provide P/E
for Chong Kun Dang Pharmaceutical Corp.

Provide P/OCF
for Chong Kun Dang Pharmaceutical Corp.

Provide P/FCFE
for Chong Kun Dang Pharmaceutical Corp.

Provide P/B
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/S
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/GP
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/EBITDA
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/EBIT
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/OCF
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/FCFF
for Chong Kun Dang Pharmaceutical Corp.

Provide EV/IC
for Chong Kun Dang Pharmaceutical Corp.

Show me price targets
for Chong Kun Dang Pharmaceutical Corp made by professional analysts.

What are the Revenue projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past Revenue estimates
for Chong Kun Dang Pharmaceutical Corp?

What are the Net Income projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past Net Income estimates
for Chong Kun Dang Pharmaceutical Corp?

What are the EPS projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past EPS estimates
for Chong Kun Dang Pharmaceutical Corp?

What are the EBIT projections
for Chong Kun Dang Pharmaceutical Corp?

How accurate were the past EBIT estimates
for Chong Kun Dang Pharmaceutical Corp?

Compare the revenue forecasts
for Chong Kun Dang Pharmaceutical Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Chong Kun Dang Pharmaceutical Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Chong Kun Dang Pharmaceutical Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Chong Kun Dang Pharmaceutical Corp compared to its peers.

Compare the P/E ratios
of Chong Kun Dang Pharmaceutical Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Chong Kun Dang Pharmaceutical Corp with its peers.

Analyze the financial leverage
of Chong Kun Dang Pharmaceutical Corp compared to its main competitors.

Show all profitability ratios
for Chong Kun Dang Pharmaceutical Corp.

Provide ROE
for Chong Kun Dang Pharmaceutical Corp.

Provide ROA
for Chong Kun Dang Pharmaceutical Corp.

Provide ROIC
for Chong Kun Dang Pharmaceutical Corp.

Provide ROCE
for Chong Kun Dang Pharmaceutical Corp.

Provide Gross Margin
for Chong Kun Dang Pharmaceutical Corp.

Provide Operating Margin
for Chong Kun Dang Pharmaceutical Corp.

Provide Net Margin
for Chong Kun Dang Pharmaceutical Corp.

Provide FCF Margin
for Chong Kun Dang Pharmaceutical Corp.

Show all solvency ratios
for Chong Kun Dang Pharmaceutical Corp.

Provide D/E Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide D/A Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Interest Coverage Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Altman Z-Score Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Quick Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Current Ratio
for Chong Kun Dang Pharmaceutical Corp.

Provide Cash Ratio
for Chong Kun Dang Pharmaceutical Corp.

What is the historical Revenue growth
over the last 5 years for Chong Kun Dang Pharmaceutical Corp?

What is the historical Net Income growth
over the last 5 years for Chong Kun Dang Pharmaceutical Corp?

What is the current Free Cash Flow
of Chong Kun Dang Pharmaceutical Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Chong Kun Dang Pharmaceutical Corp.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Chong Kun Dang Pharmaceutical Corp

Current Assets 994.9B
Cash & Short-Term Investments 338.7B
Receivables 309.1B
Other Current Assets 347.1B
Non-Current Assets 473.1B
Long-Term Investments 69.2B
PP&E 317.3B
Intangibles 66.3B
Other Non-Current Assets 20.4B
Current Liabilities 501.1B
Accounts Payable 231.4B
Accrued Liabilities 13.6B
Short-Term Debt 91B
Other Current Liabilities 165.2B
Non-Current Liabilities 94.6B
Long-Term Debt 40.3B
Other Non-Current Liabilities 54.2B
Efficiency

Earnings Waterfall
Chong Kun Dang Pharmaceutical Corp

Revenue
1.7T KRW
Cost of Revenue
-1T KRW
Gross Profit
655.6B KRW
Operating Expenses
-418.8B KRW
Operating Income
236.8B KRW
Other Expenses
-24B KRW
Net Income
212.8B KRW

Free Cash Flow Analysis
Chong Kun Dang Pharmaceutical Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Chong Kun Dang Pharmaceutical Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROE
Exceptional ROE
Positive ROIC
57/100
Profitability
Score

Chong Kun Dang Pharmaceutical Corp's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Chong Kun Dang Pharmaceutical Corp's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

82/100
Solvency
Score

Chong Kun Dang Pharmaceutical Corp's solvency score is 82/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Chong Kun Dang Pharmaceutical Corp

Wall Street analysts forecast Chong Kun Dang Pharmaceutical Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Chong Kun Dang Pharmaceutical Corp is 146 403.12 KRW with a low forecast of 101 000.01 KRW and a high forecast of 168 000 KRW.

Lowest
Price Target
101 000.01 KRW
7% Upside
Average
Price Target
146 403.12 KRW
56% Upside
Highest
Price Target
168 000 KRW
79% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Chong Kun Dang Pharmaceutical Corp?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Chong Kun Dang Pharmaceutical Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp

Country

Korea

Industry

Pharmaceuticals

Market Cap

1.2T KRW

Dividend Yield

1.17%

Description

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Contact

SEOUL
Seoul
8, Chungjeong-ro, Seodaemun-gu
+82221940300
www.ckdpharm.com

IPO

2013-12-06

Employees

-

Officers

President, CEO & Chairman
Mr. Young-Joo Kim

See Also

Discover More
What is the Intrinsic Value of one Chong Kun Dang Pharmaceutical Corp stock?

The intrinsic value of one Chong Kun Dang Pharmaceutical Corp stock under the Base Case scenario is 98 114.35 KRW.

Is Chong Kun Dang Pharmaceutical Corp stock undervalued or overvalued?

Compared to the current market price of 94 000 KRW, Chong Kun Dang Pharmaceutical Corp is Undervalued by 4%.

Back to Top